Le Lézard
Classified in: Health
Subjects: NPT, POL, AVO

AMCP CEO Susan A. Cantrell, RPh, CAE, Issues Statement on White House 2019 Budget Proposal


ALEXANDRIA, Va., Feb. 12, 2018 /PRNewswire-USNewswire/ -- Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, issued the following statement on President Trump's budget proposal for fiscal year 2019. The proposal, released today, considers many pharmacy-related issues, including opioid management, Medicaid, Medicare Part B, the 340B program and the Food and Drug Administration.

Academy of Managed Care Pharmacy. (PRNewsFoto/Academy of Managed Care Pharmacy)

"AMCP appreciates that the White House focuses so much attention on crucial issues affecting the safety, availability and affordability of pharmaceuticals.

"In particular, the opioid abuse crisis has devastated lives and communities across the country. We applaud efforts to seriously address this crisis, including by improving the use of state prescription drug monitoring programs (PDMPs) and expanded Medicaid coverage of medication assisted treatments (MAT) for addiction.

"We also applaud common-sense measures in the proposal that address pharmaceutical issues, such as streamlining the Food and Drug Administration approval processes to encourage approval of more affordable generics. We also support the proposal to allow five state Medicaid programs to implement demonstration projects with innovative approaches to medication coverage and payments, including by allowing the use of private sector approaches such as formularies and other management tools.   

"AMCP will carefully evaluate the entire proposal over the coming days and weeks. We stand ready to work with the Administration and lawmakers with advice from our perspective of representing the professionals who manage pharmacy benefits for more than 270 million Americans. Our goal is to implement common-sense programs that ensure all patients have access to needed medications while also controlling costs."

About AMCP
The Academy of Managed Care Pharmacy is the nation's leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy's 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 250 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government. www.amcp.org.

SOURCE Academy of Managed Care Pharmacy


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: